• 한국전기전자재료학회논문지
• /
• 제23권10호
• /
• pp.826-830
• /
• 2010

This study examined the effect of the scattering dose on the thyroid during a mammography examination. One hundred subjects for a mammography examination were enrolled in this study. The average glandular dose (AGD) and thyroid scattering dose (TSD) were measured. Statistical analysis was carried out using the percentage, t-test and co-variance. The mean radiation exposure to the breast and thyroid was $1.08{\pm}0.16$ and $0.14{\pm}0.04$ mGy, respectively. The percentage TSD to the AGD was 31.19%. There was no difference between the Rt. and Lt., and CC to MLO, and radiation dose to the TSD was 13.78% of the breast. Therefore, the volume of radiation exposure to the thyroid was 54.12% in a single routine mammography examination. These results suggest that the TSD was increased by increasing radiation dose to the breast. A thyroid protector is considered necessary to decrease the level of radiation exposure.

• 대한두경부종양학회지
• /
• 제14권2호
• /
• pp.214-219
• /
• 1998

Objectives: To assess the effectiveness of the low-dose(30mCi) I-131 ablation therapy for remnant thyroid tissue following total thyroidectomy for differentiated thyroid cancer. Methods: Between March 1995 and December 1997, forty-eight patients were given ablative doses(30mCi) of I-131 after total thyroidectomy for differentiated thyroid cancer in the presence of I-131 uptake in remnant thyroid tissue. Effective ablation of remnant thyroid tissue was determined by following I-131 whole body scan. if remnant thyroid tissue remained, we repeated the same management at 6 months interval. Results: Thirty-eight(79.1%) patients had papillary, 8(16.7%) follicular, 1(2.1%) medullary and 1(2.1%) Hurthle cell type cancer. Forty-eight patients underwent total thyroidectomy, among those central neck dissection was performed in 35 cases, and modified radical neck dissection in 14 cases. Postoperative complication developed in 8 cases, which included 4 cases of transient hypoparathyroidism, 1 case of permanent hypoparathyroidism, 2 cases of transient recurrent laryngeal nerve palsy, and 1 case of wound hematoma. There were significant remnant thyroid tissue in 46 cases(95.8%) of patients after total thyroidectomy, which could be ablated by low dose(30mCi) I-131. There were no statistical difference between operative procedures and number of treatment of I-131. Conclusions: These results suggested that repeated low-dose(30mCi) I-131 therapy would be needed, therefore, high -dose I-131 therapy could be considered as ablation therapy for the remnant thyroid tissue after total thyroidectomy for differentiated thyroid cancer.

• Journal of Radiation Protection and Research
• /
• 제48권1호
• /
• pp.15-19
• /
• 2023

Background: Cone beam computed tomography (CBCT) is a specialized medical equipment and plays a significant role in the diagnosis of oral and maxillofacial diseases and abnormalities; however, it is attributed to risk of exposure of ionizing radiation. The aim of the study was to estimate and determine the amount of scattered radiation dose to the thyroid gland in dental CBCT during maxilla and mandible scan. Materials and Methods: The average scattered radiation dose for i-CAT 17-19 Platinum CBCT (Imaging Sciences International) was measured using a Multi-O-Meter (Unfors Instruments), placed at the patient's neck on the skin surface of the thyroid cartilage, with an exposure parameter of 120 kVp and 37.07 mAs. The surface entrance dose was noted using the Multi-O-Meter, which was placed at the time of the scan at the level of the thyroid gland on the anterior surface of the neck. Results and Discussion: The surface entrance dose to the thyroid from both jaws scans was 191.491±78.486 µGy for 0.25 mm voxel and 26.9 seconds, and 153.670±74.041 µGy from the mandible scan, whereas from the maxilla scan the surface entrance dose was 5.259±10.691 µGy. Conclusion: The surface entrance doses to the thyroid gland from imaging of both the jaws, and also from imaging of the maxilla and mandible alone were within the threshold limit. The surface entrance dose and effective dose in CBCT were dependent on the exposure parameters (kVp and mAs), scan length, and field of view. To further reduce the radiation dose, care should be taken in selecting an appropriate protocol as well as the provision of providing shielding to the thyroid gland.

• Journal of Radiation Protection and Research
• /
• 제45권1호
• /
• pp.2-10
• /
• 2020

Background: Huge amounts of radionuclides were released into the environment due to the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident, which caused not only serious contamination on the ground, but also radiation exposure to the public. One problem that remains in performing the dose estimation is the difficulty of estimating the internal thyroid dose due to the intake of radioiodine (mainly, ¹³¹I) because of limitations to the human data available. Materials and Methods: The relevant papers were collected and reviewed by the authors. The results of thyroid dose estimates from different studies were tabulated for comparison. Results and Discussion: The thyroid dose estimates from the studies varied widely. The dose estimates by the United Nations Scientific Committee on the Effects of Atomic Radiation were higher than the others due to the ingestion dose being based on conservative assumptions. The dose estimates by Japanese experts were mostly below 20-30 mSv. The recent studies suggested that exposure on March 12, 2011 would be crucial for late evacuees from the areas near the FD-NPP because of the possible intake of short-lived radionuclides other than ¹³¹I. Further multilateral studies are vital to reduce uncertainties in the present dose estimations. Conclusion: The estimation of the thyroid doses to Fukushima residents still has many uncertainties. However, it is considered unlikely that the thyroid doses exceeded 50 mSv except in some extreme cases. Further multilateral studies are thus necessary to reduce the uncertainties in the present dose estimations.

• 대한방사선기술학회지:방사선기술과학
• /
• 제44권3호
• /
• pp.189-194
• /
• 2021

This study was conducted to reduce the exposure dose to the breast and adjacent organs as the number of Mammography increased. Therefore, it has been designed a shield in lead, bismuth + tungsten, and bismuth that does not require to be equipped by the patient, in which each type of shield was compared and analyzed of radiation exposure dose to breast, thyroid, and eye. Using a mammography machine, optically stimulated luminescent dosimeter(OSLD) was inserted to bilateral breast, thyroid, and eye of a dosimetry phantom to measure dose radiated onto the phantom. Shielding device was made in different thickness of 2mm, 3mm, and 5mm and dose evaluation was performed by measuring the dose while using lead, bismuth, and bismuth + tungsten prosthesis. When each shields combined with shielding device, were compared of dose, all showed similar does reduction in the dose to breast, thyroid, and eye in both cranialcaudal and mediolateraloblique view. Based on the current study, bismuth and bismuth + tungsten can replace conventional lead shield and it is anticipated to safely and conveniently reduce radiation exposure to breast, thyroid, and eye with the shield that does not require to be equipped.

• Radiation Oncology Journal
• /
• 제16권4호
• /
• pp.517-529
• /
• 1998

목적 : 정위방사선수술은 뇌동정맥기형 및 청신경초종, 뇌수막종양, 뇌하수체종양 뿐만 아니라 단일 전이성 종양의 치료에 있어서도 그 이용의 빈도가 급격히 늘어나는 추세이다. 그에 따라 목표부위에 있어서 정위방사선술의 선량분포에 관한 연구는 많이 발표되고 있으나 두 개강 외의 수정체 갑상선과 같이 방사선의 결정적 또는 확률적 효과에 민감한 장기와 같은 조직에서 흡수되는 선량에 관한 자료는 극히 제한적이다. 본 연구는 인체모형에서 방사선수술시 수정체 및 갑상선의 선량을 측정하고 그 선량에 영향을 미치는 변수를 규명하고자 하였다. 대상 및 방법 : 6 곳의 상이한 회전중심점에서 각각 서울대학교 의과대학 치료방사선과학교실에서 개발한 선형가속기형 정위방사선수술 기법을 이용하여 치료계획을 세웠다. 각 회전중심점당 6개의 arc를 기본으로 하고 각 arc의 범위는 100도를 기준으로 하고 보조콜리메이터 크기는 직경 2cm로 선정하였다. 각 arc 별로 250cGy 조사한 후 내회 열형광선량계를 이용하여 수정체 및 갑상선의 표면에 미치는 선량을 측정하였다. 결과 : 회전중심점 또는 arc plane 이 각 장기와 가까울수록 흡수 선량이 높았다. exit beam이 수정체나 갑상선을 지나지 않을 경우 각 장기의 선량은 최대선량의 0.23$\pm$0.08$\%$ 와 0.18$\pm$0.05$\%$ 이고, exit beam 이 수정체나 갑상선을 지나는 경우 각 장기의 선량은 최대선량의 0.76$\pm$0.12$\%$ 와 0.41$\pm$0.04$\%$ 이다. exit beam의 통과 여부가 각 장기의 선량에 미치는 가장 큰 인자이며, 장기를 통과하는 arc에 의해 흡수하는 선량은 총 선량의 80$\%$를 차지한다. 인체 모형의 표면선량과 5mm 깊이에서의 선량에 큰 차이가 없어 표면선량을 수정체 및 갑상선 선량으로 대체할 수 있다고 판단한다. 결론 : 정위방사선수술시 인체모형의 수정체와 갑상선에 흡수되는 방사선량을 측정한 결과 회전중심점 및 arc plane 이 각 장기와 가까울수록 높은 흡수 선량을 나타내었으며, exit beam이 수정체나 갑상선을 통과하는 경우 흡수선량이 높았고 exit beam의 통과 여부가 각 장기의 흡수선량에 가장 큰 영향을 미쳤다. 또한 수정체와 갑상선의 표면선량은 수정체 및 갑상선 선량과 큰 차이가 없었다. 최적의 방사선수술을 위한 계획을 수립할 경우 각 장기의 선량은 최대 1$\%$ 미만으로 후유증을 일으키기에 낮은 선량이기는 하나, 특히 소아 등에서는 갑상선 선량을 가능한 낮추어야 할 것이다.

• 한국산학기술학회논문지
• /
• 제13권5호
• /
• pp.2278-2284
• /
• 2012

파노라마방사선촬영 시 방사선감수성이 높은 갑상선의 방사선 피폭을 최소화하면서 진단에 유용한 영상을 얻기 위하여 조직등가물질인 보루스(bolus)를 차폐체로 사용하여 피폭선량 감소효과를 측정하였다. 실험은 2011. 6. 1일부터 6. 30일까지 두경부팬톰을 이용하여 갑상선 위치의 표면입사선량과 심부흡수선량을 측정하였다. 그 결과 갑상선 부위 입사표면선량은 평균 43.84 ${\mu}Gy$이었고, 10 mm 두께의 보루스로 만든 갑상선보호대에서는 평균 28.39 ${\mu}Gy$로 15.45 ${\mu}Gy$(35.24%)가 감소되었다. 20 mm 갑상선보호대를 착용했을 경우에는 평균 25.38 ${\mu}Gy$로 미착용 시 평균 43.84 ${\mu}Gy$보다 18.46 ${\mu}Gy$(42.10%)가 감소되었다. 그리고 표면에서 20 mm 깊이에서는 10 mm 두께의 갑상선보호대는 선량 감소효과가 없었고, 20 mm 갑상선보호대를 착용했을 경우에는 0.06 mSv (20%)의 선량감소효과가 있었다.

• 한국동물학회지
• /
• 제3권1호
• /
• pp.19-23
• /
• 1960

A method for determination of thyroid secretion rate in rabbit by means of radioactive iodine presented. After injection of radioactive iodine, in vivo determination so f radioactivity in thyroid gland were made during a 19 day-experimental period. In the same period blood samples were drawn and analyzed for protein-bound iodine (PBI) and for protein-bound radioactive iodine(PBI181). A rate constant for secretion of thyroid hormone was calculated from the disappearance rate of radioactive iodine in thyroid gland. The secretion rate of radioactive hormone iodine was calculated by multiplying this rate constant by the amount of radioactive iodine present in thyroid gland. Assuming that the specific radioactiveness of the circulating thyroid hormone and of the hormone just secreted were identical , thyroid secretion rate was calculated by the equation. {{{{ { Secreted hormone-iodine , gamma /hr} over { Secreted hormone-I^131, % dose/hr }= { PBI, ${\gamma}$/ml.Serum} over { PBI^131 , % dose/ml . Serum } }} The method presented consisted of measurements for series of independent criteria on thyroid function, and the resulting thyroid secretion rate was calculated by combination of those.

• 대한방사선치료학회지
• /
• 제26권2호
• /
• pp.265-272
• /
• 2014

목 적 : 전뇌 방사선 치료 시 산란선으로 인하여 영향을 받는 갑상선의 피폭선량을 감소시키기 위해 차폐체를 사용하여 갑상선의 차폐 효과를 평가하고자 한다. 대상 및 방법 : 갑상선의 피폭선량을 측정하기 위해 선형가속기(Clinac iX. VARIAN, USA)를 이용하여 6 MV X선, 300 cGy를 인체모형팬텀에 대향 2문 조사하였다. 갑상선의 입사표면선량을 측정하기 위해 인체모형팬텀의 10번째 슬라이스 표면에 유리선량계 다섯 개를 1.5 cm 간격으로 위치시킨 후 차폐체 미사용, bismuth 차폐체 사용, 0.5 mmPb 차폐체 사용, 자체 제작한 1.0 mmPb 차폐체를 사용하여 각각 5회씩 측정하여 평균값을 산출하였다. 또한, 같은 위치에서 갑상선 심부선량을 측정하기 위해서 인체모형팬텀의 10번째 슬라이스 2.5 cm 깊이에서 유리선량계 다섯 개를 1.5 cm 간격으로 위치시킨 후 차폐체 미사용, bismuth 차폐체 사용, 0.5 mmPb 차폐체 사용, 자체 제작한 1.0 mmPb 차폐체를 사용하여 각각 5회씩 측정하여 평균값을 산출하였다. 결 과 : 갑상선의 입사표면선량은 차폐체 미사용 시 44.89 mGy로 측정되었고, bismuth 차폐체는 36.03 mGy, 0.5 mmPb 차폐체는 31.03 mGy, 자체 제작한 1.0 mmPb 차폐체는 23.21 mGy로 측정되었다. 또한, 갑상선의 심부선량은 차폐체 미사용 시 36.10 mGy로 측정되었고, bismuth 차폐체는 34.52 mGy, 0.5 mmPb 차폐체는 32.28 mGy, 자체 제작한 1.0 mmPb 차폐체는 25.50 mGy로 측정되었다. 결 론 : 전뇌 방사선 치료 시 방사선 조사면 밖의 영역에서 발생하는 이차 산란 및 누출 선량에 의해 영향을 받는 갑상선에 대하여 차폐체를 사용했을 때 갑상선 심부는 약 11~30%, 갑상선 표면은 약 20~48% 정도의 피폭선량 감소 효과가 나타났다. 따라서 전뇌 방사선 치료 시 갑상선 차폐체를 사용함으로써 갑상선을 효과적으로 보호하며 치료를 시행할 수 있을 것으로 사료된다.

• Journal of Radiation Protection and Research
• /
• 제35권1호
• /
• pp.1-5
• /
• 2010

This study concerning the surface dose of eye and thyroid from panoramagraphy used thermoluminescent dosimeter (TLD) and photoluminescent dosimeter (PLD) to take measurements at ten hospitals in the Gwangju metropolitan area. The recommendations from ICRP 60 and ICRP 73 on the allowance standard for eye are 15 mSv and for thyroid is 1 mSv. The left eye TLD and PLD values are 0.19 mSv and 0.24 mSv respectively. The right eye TLD and PLD values are 0.23 mSv and 0.25 mSv respectively. Thyroid TLD and PLD values are 0.08 mSv and 0.25 mSv respectively and did not exceed the allowance standards(p<0.001). Also comparisons are made between TLD and PLD for each organ and PLD has higher dose measurements than TLD. There are statistically significant differences in left eye measurements and thyroid measurements (p<0.01). There is no significant difference in measurements for the right eye (p>0.05). The TLD and PLD measured dose from panoramagraphy instruments on eyes and thyroid from each hospital did not exceed the recommended dose from ICRP 60 for surface dose measurements. However, due to the probability of influence, consideration should be made for all levels of dose.